Abstract
Objective
To investigate the efficacy and safety of the Chinese herbal therapeutic regimen of activating blood circulation (TRABC) in treatment of hypertensive intracerebral hemorrhage (HICH).
Methods
This was a multi-center prospective randomized open-label blinded-endpoint (PROBE) trial with HICH admitted to 12 hospitals. Totally 240 participants were randomized to the treatment group treated with TRABC in addition to conventional Western treatment or the control group with conventional Western treatment equally for 3 months. Primary outcome was degree of disability as measured by modified Rankin Scale (mRS). Secondary outcomes were the absorption of hematoma and edema, National Institutes of Health Stroke Scale (NIHSS) scores and patient-reported outcome measures for stroke and Barthel activities of daily living index. Adverse events and mortality were also recorded.
Results
After 3 months of treatment, the rate of mRS 0-1 and mRS 0-2 in the treatment group was 72.5% and 80.4%, respectively, and in the control group 48.1% and 63.9%, respectively, with a significant difference between groups (P<0.01). Hematoma volume decreased significantly at day 7 of treatment in the treatment group than the control group (P=0.038). Average Barthel scores in the treatment group after treatment was 89.11±19.93, and in the control group 82.18±24.02 (P=0.003). NIHSS scores of the two groups after treatment decreased significantly compared with before treatment (P=0.001). Patient-reported outcomes in the treatment group were lower than the control group at day 21 and 3 months of treatment (P<0.05). There were 4 deaths, 2 in each group, and 11 adverse events, 6 in the treatment group and 5 in the control group.
Conclusion
The integrative therapy combined TRABC with conventional Western treatment for HICH could promote hematoma absorption thus minimize neurologic impairment, without increasing intracerebral hematoma expansion and re-bleeding.
Similar content being viewed by others
References
Cheung RT. Update on medical and surgical management of intracerebral hemorrhage. Rev Recent Clin Trials 2007;2:174–181.
Zurasky JA, Aiyagari V, Zazulia AR, Shackelford A, Diringe MN. Early mortality following spontaneous intracerebral hemorrhage. Neurology 2005;64:725–727.
Kuramatsu JB, Huttner HB, Schwab S. Advances in the management of intracerebral hemorrhage. J Neural Transm 2013;120 (Suppl) 1:S35–S41.
Jade WW, Huang YN, Wang JG, Liu M, Lawrence KSW, Huang QF, et al. Current management of intracerebral hemorrhage in China: a national, multi-centre, hospital registers study. BMC Neurol 2011;11:16.
Cui JT, Liu JX. Research of integrated Chinese and Western medicine in treatment of hypertensive cerebral hemorrhage. J Hubei Univ Chin Med (Chin) 2014;1:115–117.
Fan ML, Zhou GX. Effects of Xingnaojing on cerebral edema and the expressions of matrix metalloproteinase-9 and complement 3 around hematoma after intracerebral hemorrhage in rats. Chin J Contemp Neurol Neurosurg (Chin) 2009;3:284–289.
Zhou QB, LI LY, Jia Q. Protective effect of Naoningkang Granule on brain in intracerebral hemorrhagic rats. Chin J Integr Tradit West Med (Chin) 2007;9:814–818.
Feng Z, Lou YY. Curative effect observation of the integrative medicine on treating cerebral hemorrhage. Clin J Chin Med (Chin) 2013;17:8–10.
An B, Jiang YC, Kang XH, Cao F, Chen GH. Clinical study of Shuanghuang Tongfu Granules in treatment of intracerebral hemorrhage. Hubei J Tradit Chin Med (Chin) 2014;36:9–10.
Chen ZG, Wang SL, Meng FX, Han G, Lin S, Guo RJ, et al. Retrospective analysis of acute hemorrhagic stroke treated with the method of activating blood circulation to remove stasis. Chin J Inf Tradit Chin Med (Chin) 2007;14(7):15–17.
Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 2007;38:1091–1096.
Bae C, Andrefsky JC, Degeorgia MA. NIHSS predicts outcome better than GCS in intracerebral hemorrhage. Stroke 2001;32:356–357.
Chinese Society of Neurology. Chinese Cerebrovascular Disease Guideline, 2005. J Apoplexy Nerv Dis (Chin) 2006;23:132-134.
Zhang C, Gao Y. Current issues in application of the standards for syndrome differentiation and diagnosis of stroke. Tianjin J Tradit Chin Med (Chin) 2007;24:12–14.
Zhu Y, Qi S, Wu H, Xiang Z. Study on the improvement of Coniglobus formula based on subdural hematoma volume estimates. Neurosurgery Quarterly 2015;25:275–279.
Gian Luca DP, Katia S, Elodie O, Monica R, Francesco M, Leone MA. Validity and reliability of the Barthel index administered by telephone. Stroke 2011;42:2077–2079.
Zhang GM, Zhou L, Cui FY, Chen Y, Chen H, Cen K, et al. Etiology and pathophysiology of hemorrhagic stroke. Chin J Integr Med Cardio-Cerebrovasc Dis (Chin) 2013;11:87–88.
Zhang GM, Zhou L, Ma B, Cui FY, Chen H. Traditional Chinese medicine treatment of cerebral hemorrhage based on activating blood circulation to remove stasis: methodology and theoretic basis. Chin J Pharmacovigil (Chin) 2013;10:352–354.
Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 2006;5:53–63.
Yang WM, Li QL. Current status of application of activating blood circulation to remove stasis in treatment of acute cerebral hemorrhage. Clin J Tradit Chin Med (Chin) 2010;22:944–947.
Liu H, Zhang GP, Song SJ, Ding MP, Zhou JF, Bie XD, et al. Clinical study on Zhuyu Tongfu Serial Recipe combined with acupuncture and massotherapy in treating hypertensive cerebral hemorrhage. Chin J Integr Tradit West Med (Chin) 2005;11:167–172.
Zhu DS, Xu MH, Wei HC. Traditional Chinese prescriptions for treatment of acute cerebral hemorrhage. Chin J Integr Tradit West Med Intens Critic Care (Chin) 2000;7:133–136.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the Beijing Committee on Science and Technology, Project on Research on Two Standards of Traditional Chinese Medicine Treatment for Stroke (No. D101107049310003)
Rights and permissions
About this article
Cite this article
Li, Jy., Yuan, Lx., Zhang, Gm. et al. Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: A multi-center prospective randomized open-label blinded-endpoint trial. Chin. J. Integr. Med. 22, 328–334 (2016). https://doi.org/10.1007/s11655-016-2467-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-016-2467-7